Why the Non Small Cell Lung Cancer Therapeutics Market Is Set to Explode? Top Companies: Genentech (F. Hoffmann-La Roche Ltd), Eli Lilly and Company, Celgene Corporation, Others
The global non-small cell lung cancer therapeutics market is growing impressively due to recent surge in adoption of targeted therapy for treating non-small cell lung cancer. According to a report published by Fortune Business Insights, titled 'Non-Small Cell Lung Cancer Therapeutics: Global Market Analysis, Insights and Forecasts, 2019-2026,' the market value will rise substantially from US$ 16,011.7 Mn in 2018 to US$ 43,713.1 Mn by 2026. Fortune Business Insights has further predicted the market to exhibit an impressive CAGR of...
View full press release